Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial

Paul M. Ridker, Eleanor Danielson, Francisco A.H. Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Wolfgang Koenig, Peter Libby, Alberto J. Lorenzatti, Jean G. MacFadyen, Børge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial'. Together they form a unique fingerprint.